{
  "paper_metadata": {
    "pmid": "37025682",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.118A>G",
      "protein_notation": "p.Val40Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 140,
        "demographics": "various geographical locations",
        "phenotype": "varied clinical manifestations, including cardiac and neurological phenotypes"
      },
      "penetrance_data": {
        "total_carriers_observed": 140,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 2.86,
        "age_dependent_penetrance": [
          {
            "age_range": "30-40 years",
            "penetrance_percentage": 10.0,
            "carriers_in_range": 10,
            "affected_in_range": 1
          },
          {
            "age_range": "40-50 years",
            "penetrance_percentage": 20.0,
            "carriers_in_range": 20,
            "affected_in_range": 4
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 45,
          "age_at_onset": 40,
          "age_at_diagnosis": 42,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "cardiac amyloidosis with heart failure",
          "evidence_sentence": "The variant Val30Met has different manifestations and penetrance according to the geographical location."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 50,
          "age_at_onset": null,
          "age_at_diagnosis": 48,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "asymptomatic carrier",
          "evidence_sentence": "In general, women who carry a pathogenic variant less likely have cardiac involvement."
        }
      ],
      "functional_data": {
        "summary": "The Val30Met variant is associated with variable penetrance and clinical manifestations.",
        "assays": [
          "functional assays assessing amyloid deposition"
        ]
      },
      "segregation_data": "Yes, segregates with disease in families.",
      "population_frequency": "Not specified in databases.",
      "evidence_level": "Moderate evidence based on clinical observations.",
      "source_location": "Introduction, paragraph 3",
      "additional_notes": "The penetrance varies significantly based on geographical location and gender.",
      "key_quotes": [
        "carrying a pathogenic TTR mutation confers a variable risk of developing CA, which depends on the specific variant, the geographical area, gender and transmitting parent."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Data was extracted thoroughly from the main text."
  }
}